US 10967051
Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof
granted A61KA61K38/26A61K38/28
Quick answer
US patent 10967051 (Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof) held by Oramed Ltd. expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Oramed Ltd.
- Grant date
- Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/26, A61K38/28, A61K38/55, A61K38/56